Related Experiment Videos
[Prostate cancer diagnosed before 55: a retrospective study from the Rare Cancer Network]
Tan Dat Nguyen1, Philip M P Poortmans, Marleen van der Hulst
1Institut Jean-Godinot (IJG),département d'oncologie-radiothérapie, BP 171, 51000 Reims.
Bulletin Du Cancer
|January 7, 2005
Summary
This study found that younger men diagnosed with prostate cancer (PCa) can achieve good survival rates with adequate treatment. Age is not a negative prognostic factor for PCa when curative therapies are employed.
Area of Science:
- Oncology
- Urology
- Cancer Research
Context:
- Prostate cancer (PCa) diagnosis before age 55 is uncommon.
- Treatment strategies for PCa have evolved significantly over time.
- Understanding outcomes for early-onset PCa is crucial for optimizing care.
Purpose:
- To analyze treatment modalities and outcomes for prostate cancer diagnosed before age 55.
- To evaluate the impact of different treatments on survival and failure rates.
- To inform future treatment strategies and management policies for young PCa patients.
Summary:
- A retrospective study analyzed 365 patients diagnosed with PCa before age 55 between 1974-2001.
- Treatments included radical prostatectomy, radiation therapy, hormonal manipulation, and palliative care.
- Multivariate analysis showed radiotherapy impacted failure rates, T stage affected distant failure, and nodal involvement influenced survival.
Impact:
- Age is not a negative prognostic factor for prostate cancer with adequate curative treatment.
- Radiotherapy significantly impacts local and distant failure rates.
- Further research with longer follow-up is needed to evaluate evolving treatment efficacies.